ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

ClinicalTrials.gov ID: NCT05196035

Public ClinicalTrials.gov record NCT05196035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-month Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and PK/PD of an age-and Body Weight-adjusted Oral Finerenone Regimen, in Addition to an ACEI or ARB, for the Treatment of Children, 6 Months to <18 Years of Age, With Chronic Kidney Disease and Proteinuria

Study identification

NCT ID
NCT05196035
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
219 participants

Conditions and interventions

Interventions

  • Finerenone (Kerendia, BAY94-8862) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Months to 17 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 27, 2022
Primary completion
Jul 30, 2027
Completion
Aug 30, 2027
Last update posted
Apr 16, 2026

2022 – 2027

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Phoenix Children's Hospital | Main - Transplant Department Phoenix Arizona 85016 Terminated
Cedars-Sinai Medical Center - Nephrology Los Angeles California 90048 Withdrawn
Lucille Packard Children's Hospital Stanford - Pediatric Nephrology Palo Alto California 94304 Recruiting
UC San Diego - Altman Clinical and Translational Research Institute (ACTRI) - Linda Vista Clinic San Diego California 92023 Recruiting
Children's National Hospital - Nephrology Washington D.C. District of Columbia 20010 Not yet recruiting
Memorial Transplant Institute - Pediatric Nephrology Hollywood Florida 33021 Recruiting
Emory University Hospital/Children's Healthcare of Atlanta - Nephrology Atlanta Georgia 30322 Withdrawn
University of Iowa Health Care Medical Center - Nephrology Iowa City Iowa 52242 Not yet recruiting
The Charlotte R. Bloomberg Children's Center Building - Nephrology Baltimore Maryland 21287 Recruiting
Boston Children's Hospital - Main Campus - Nephrology Boston Massachusetts 02115 Withdrawn
Children's Mercy Hospital Kansas City - Nephrology Kansas City Missouri 64108 Recruiting
Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension Cincinnati Ohio 45229 Recruiting
Cleveland Clinic | Pediatric Nephrology Cleveland Ohio 14013 Recruiting
Nationwide Children's Hospital - Nephrology Columbus Ohio 43205 Not yet recruiting
OHSU Doernbecher Children's Hospital - Neurology Portland Oregon 97239 Recruiting
Children's Hospital of Philadelphia - Nephrology Philadelphia Pennsylvania 19104 Not yet recruiting
Univ of Texas Health Science Center | Nephrology Res Dept San Antonio Texas 78207 Withdrawn
Eccles Primary Children's Outpatient Services - Nephrology Salt Lake City Utah 84113 Recruiting
Seattle Children's Hospital - Nephrology Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 145 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05196035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05196035 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →